|
Treatment options for secondary breast ca
|
|
3
|
849
|
24 June 2024
|
|
Anastrozole Side affects
|
|
3
|
1326
|
14 June 2024
|
|
Have you received capivasertib with fulvestrant (Truqap with Faslodex)?
|
|
1
|
456
|
11 June 2024
|
|
Everolimus+Exemestane
|
|
0
|
330
|
9 June 2024
|
|
Herceptin and Coronavirus vaccines
|
|
2
|
1801
|
6 June 2024
|
|
Cape advice
|
|
2
|
466
|
5 June 2024
|
|
Capecitabine older people
|
|
12
|
1049
|
31 May 2024
|
|
Licensing new drug Tucatinib (TUKYSA), from HER2CLIMB trial
|
|
5
|
3914
|
20 May 2024
|
|
Advice please re. new diagnosis
|
|
20
|
1610
|
15 May 2024
|
|
Covid booster 2024
|
|
13
|
1013
|
11 May 2024
|
|
Researching trials and treatments abroad
|
|
1
|
368
|
10 May 2024
|
|
Secondary Private Group
|
|
29
|
24672
|
23 January 2025
|
|
BCN Response Time
|
|
6
|
742
|
27 April 2024
|
|
Oral thrush - Candida. What next?
|
|
9
|
1509
|
27 April 2024
|
|
Eribulin
|
|
3
|
1258
|
12 April 2024
|
|
Atrophy
|
|
11
|
1444
|
31 March 2024
|
|
Is Enhertu available in the UK, on the NHS
|
|
20
|
2297
|
18 March 2024
|
|
Xgeva (denosumab) and low White blood count
|
|
1
|
832
|
16 March 2024
|
|
Change of treatment - PICC or central line
|
|
12
|
638
|
16 March 2024
|
|
CA15-3 marker
|
|
7
|
2118
|
16 March 2024
|
|
Weight gain in short space of time ?
|
|
5
|
1090
|
13 March 2024
|
|
Tamoxifen Brand Change
|
|
3
|
713
|
10 March 2024
|
|
Terrible balance problem
|
|
7
|
1064
|
8 February 2024
|
|
Cancer Research Awareness
|
|
0
|
383
|
4 February 2024
|
|
Xeloda and bone recurrence
|
|
3
|
612
|
31 January 2024
|
|
Atezolizumab and Nab-paclitaxel (Abraxane) experience
|
|
5
|
1753
|
30 January 2024
|
|
About to start Trodelvy, any information please
|
|
6
|
4036
|
28 January 2024
|
|
Xeloda delay
|
|
13
|
965
|
21 January 2024
|
|
The dreaded canula
|
|
12
|
916
|
11 January 2024
|
|
Sacituzumab govitecan (Trodelvy)
|
|
3
|
1577
|
11 January 2024
|